World Journal of Experimental Medicine - Baishideng Publishing Group

Advanced Search

BPG is committed to discovery and dissemination of knowledge

JOURNAL HOME

Number of total visits: 853261

Number of visits today: 1044

Number of downloads: 663967

INDEXING/ABSTRACTING

MEMBERSHIP

BPG JOURNALS

Open-Access Journal

Other Issues: Previous | Next | Latest | Archive | Download full issue 4 (289)

Contents Volume 13 Issue 4 September 20, 2023

Review

Neurologic orphan diseases: Emerging innovations and role for genetic treatments

Ivelina P Kioutchoukova, Devon T Foster, Rajvi N Thakkar, Marco A Foreman, Brandon J Burgess, Rebecca M Toms, Eduardo E Molina Valero, Brandon Lucke-Wold

World J Exp Med 13(4):59-74. Published online Sep 20, 2023. doi: 10.5493/wjem.v13.i4.59

Abstract (1111) | Core Tip (1044) | Full Article (HTML) (4005) | Figures (1-5) (507) | Full Article (PDF)-2841K (271) | Full Article with Cover (PDF)-3034K (197) | Full Article (XML)-303K (113) | Audio-333K (4) | Peer-Review Report-234K (125) | Answering Reviewers-110K (135) | Received: 06/17/2023 | Revised: 07/16/2023 | Accepted: 08/11/2023 | RCA | PubMed Central | PubMed | CrossRef | Google Scholar | Times Cited (5) | Total Visits (9835) | Similar Articles (0) | Timeline of Article Publication (4) | Authors Evaluation (2) | Article Quality Tracking (1) | What about the content of this article? (0) | Cite |

(0) | Open

Basic Study

Personalized clinical managements through exploring circulating neural cells and electroencephalography

Parvin Mehdipour, Nima Fathi, Masoud Nosratabadi

World J Exp Med 13(4):75-94. Published online Sep 20, 2023. doi: 10.5493/wjem.v13.i4.75

Abstract (911) | Core Tip (1038) | Article Highlights (983) | Full Article (HTML) (2515) | Figures (1-13) (471) | Tables (1-2) (441) | Full Article (PDF)-18536K (222) | Full Article with Cover (PDF)-18729K (179) | Full Article (XML)-148K (115) | Audio-2276K (8) | Peer-Review Report-245K (110) | Answering Reviewers-304K (119) | Received: 01/20/2023 | Revised: 05/22/2023 | Accepted: 07/11/2023 | RCA | PubMed Central | PubMed | CrossRef | Google Scholar | Times Cited (0) | Total Visits (10129) | Similar Articles (3) | Timeline of Article Publication (3) | Authors Evaluation (1) | Article Quality Tracking (1) | What about the content of this article? (0) | Cite |

(0) | Open

Letter to the Editor

Ophthalmologic implications to consider when using hydroxychloroquine to treat COVID-19 and induced arthritis

Marco Zeppieri

World J Exp Med 13(4):95-98. Published online Sep 20, 2023. doi: 10.5493/wjem.v13.i4.95

Abstract (1043) | Core Tip (977) | Full Article (HTML) (2441) | Full Article (PDF)-359K (153) | Full Article with Cover (PDF)-553K (146) | Full Article (XML)-43K (138) | Audio-345K (7) | Peer-Review Report-218K (113) | Answering Reviewers-111K (118) | Received: 04/21/2023 | Revised: 05/16/2023 | Accepted: 06/16/2023 | RCA | PubMed Central | PubMed | CrossRef | Google Scholar | Times Cited (0) | Total Visits (7982) | Similar Articles (711) | Timeline of Article Publication (0) | Authors Evaluation (1) | Article Quality Tracking (2) | What about the content of this article? (0) | Cite |

(0) | Open

Update on hydroxychloroquine use in pregnancy

Wassan Nori, Nabeeha Najatee Akram, Raid M Al-Ani

World J Exp Med 13(4):99-101. Published online Sep 20, 2023. doi: 10.5493/wjem.v13.i4.99

Abstract (1166) | Core Tip (1194) | Full Article (HTML) (3589) | Full Article (PDF)-351K (220) | Full Article with Cover (PDF)-545K (170) | Full Article (XML)-43K (127) | Audio-1788K (6) | Peer-Review Report-230K (117) | Answering Reviewers-85K (107) | Received: 04/13/2023 | Revised: 07/05/2023 | Accepted: 07/24/2023 | RCA | PubMed Central | PubMed | CrossRef | Google Scholar | Times Cited (2) | Total Visits (9470) | Similar Articles (144) | Timeline of Article Publication (0) | Authors Evaluation (5) | Article Quality Tracking (2) | What about the content of this article? (0) | Cite |

(0) | Open

Write to the Help Desk

© 2004-2025 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

California Corporate Number: 3537345